Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant DNASE1, DNASE1L3, DNASE2, and DFFB Controlled by EGFR Promoter: Novel Strategy for Targeted Therapy of Cancer

INTRODUCTION: Ovarian cancer is the most deadly among all gynecological cancers. Patients undergoing systemic therapies of advanced ovarian cancers suffer from horrendous side effects. Cancer survivors and their offspring suffer from iatrogenic consequences of systemic therapies: genetic mutations....

Descripción completa

Detalles Bibliográficos
Autores principales: Malecki, Marek, Dahlke, Jessica, Haig, Melissa, Wohlwend, Lynn, Malecki, Raf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938193/
https://www.ncbi.nlm.nih.gov/pubmed/24587967
http://dx.doi.org/10.4172/2157-7412.1000152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938193/
https://www.ncbi.nlm.nih.gov/pubmed/24587967
http://dx.doi.org/10.4172/2157-7412.1000152

Ejemplares similares